SCHEMBL20101097

SCHEMBL20101097

C/C(=N\Nc1ccc2ccccc2n1)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
CXCR5 P32302 1/20 0.68
APLNR P35414 1/20 0.68
LRRK2 Q5S007 1/20 0.68
TP53 P04637 1/20 0.68
CYP1A2 P05177 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
CYP2C19 P33261 1/20 0.68
PAX8 Q06710 2/20 0.66
RAB9A P51151 6/20 0.53
NPC1 O15118 5/20 0.53
NCF1 P14598 1/20 0.51
KMT2A Q03164 7/20 0.48
MEN1 O00255 4/20 0.48
MAPT P10636 4/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563202 0.84 NPC1 (0.55) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL14075818 0.81 SMN1; SMN2 (1.00) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL17987877 0.80 PAX8 (1.00) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL31238176 0.80 PAX8 (1.00) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL11332741 0.76 RAB9A (0.49) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL4916024 0.75 PAX8 (0.68) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL12706320 0.75 PAX8 (0.68) CCR6SMN1; SMN2CXCR5APLNRLRRK2
SCHEMBL20101098 0.72 MAPT (0.73) SMN1; SMN2PAX8RAB9ANPC1KMT2A
SCHEMBL4413307 0.70 GAA (0.69) SMN1; SMN2RAB9ANPC1KMT2AMEN1
SCHEMBL3273659 0.70 GAA (0.69) SMN1; SMN2RAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed